Are Colonoscopy and Bowel Ultrasound Useful for Assessing Response to Short-Term Therapy and Predicting Disease Outcome of Moderate-to-Severe Forms of Ulcerative Colitis?: A Prospective Study
- 1 May 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in American Journal Of Gastroenterology
- Vol. 105 (5), 1150-1157
- https://doi.org/10.1038/ajg.2009.672
Abstract
Mucosal healing has been proposed as an important sign of the efficacy of medical treatment of inflammatory bowel disease; however, direct evidence in ulcerative colitis (UC) is scarce. We evaluated the usefulness of colonoscopy and bowel ultrasound (US) as indexes of response to short-term therapy and as predictors of subsequent outcome in UC. A total of 83 patients with moderate-to-severe UC were recruited; endoscopic and US severity was graded 0–3 at entry according to validated scores. Of the recruited patients, 74, who were clinically responsive to steroids, were followed up with repeated colonoscopy and bowel US at 3, 9, and 15 months from recruitment. Concordance between clinical, endoscopic, and US scores at various visits was determined by kappa statistics. Multiple unconditional logistic regression models were used to assess the predictivity of clinical, endoscopic, and US scores measured at 3 and 9 months on the development of endoscopic UC relapse within 15 months. A variable concordance was found over time between endoscopic and clinical score (weighted κ between 0.38 and 0.95), with high and consistent concordance between endoscopic and US scores (weighted κ between 0.76 and 0.90). On logistic regression analysis, moderate-to-severe endoscopic and US scores at 3 months were associated with a high risk of endoscopic activity at 15 months (odds ratio (OR): 5.2; 95% confidence interval (CI): 1.6–17.6 and OR: 9.1; 95% CI: 2.5–33.5, respectively). Bowel US may be used as a surrogate of colonoscopy in assessing the short-term response of severe forms of UC to therapy. Both US score and endoscopic score after 3 months of steroid therapy predict outcome of disease at 15 months.Keywords
This publication has 29 references indexed in Scilit:
- Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?Gut, 2007
- The Natural History of Corticosteroid Therapy for Ulcerative Colitis in ChildrenClinical Gastroenterology and Hepatology, 2006
- The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5‐year UK inception cohortAlimentary Pharmacology & Therapeutics, 2006
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisNew England Journal of Medicine, 2005
- Guidelines for the management of inflammatory bowel disease in adultsGut, 2004
- Outcome of a conservative approach in severe ulcerative colitisDigestive and Liver Disease, 2004
- Sonographic measurement of thickened bowel wall segments as a quantitative parameter for activity in inflammatory bowel disease.Zeitschrift für Gastroenterologie, 2000
- Variation Between Observers in Describing Mucosal Appearances in ProctocolitisBMJ, 1964
- Comparison of Corticosteroid and Sulphasalazine Therapy in Ulcerative ColitisBMJ, 1962
- Cortisone in Ulcerative ColitisBMJ, 1955